Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 463

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma

Open access
Chen, Yu-Pei, Yin, Jian-Hua, Li, Wen-Fei, Li, Han-Jie, Chen, Dong-Ping, Zhang, Cui-Juan, Lv, Jia-Wei, Wang, Ya-Qin, Li, Xiao-Min, Li, Jun-Yan, Zhang, Pan-Pan, Li, Ying-Qin, He, Qing-Mei, Yang, Xiao-Jing, Lei, Yuan, Tang, Ling-Long, Zhou, Guan-Qun, Mao, Yan-Ping, Wei, Chen, Xiong, Ke-Xu, Zhang, Hong-Bo, Zhu, Shi-Da, Hou, Yong, Sun, Ying, Dean, Michael, Amit, Ido, Wu, Kui, Kuang, Dong-Ming, Li, Gui-Bo, Liu, Na, Ma, Jun·2020·Cell Research

Abstract

Nasopharyngeal carcinoma (NPC) is an aggressive malignancy with extremely skewed ethnic and geographic distributions. Increasing evidence indicates that targeting the tumor microenvironment (TME) represents a promising therapeutic approach in NPC, highlighting an urgent need to deepen the understanding of the complex NPC TME. Here, we generated single-cell transcriptome profiles for 7581 malignant cells and 40,285 immune cells from fifteen primary NPC tumors and one normal sample. We revealed malignant signatures capturing intratumoral transcriptional heterogeneity and predicting aggressiveness of malignant cells. Diverse immune cell subtypes were identified, including novel subtypes such as CLEC9A+ dendritic cells (DCs). We further revealed transcriptional regulators underlying immune cell diversity, and cell–cell interaction analyses highlighted promising immunotherapeutic targets in NPC. Moreover, we established the immune subtype-specific signatures, and demonstrated that the signatures of macrophages, plasmacytoid dendritic cells (pDCs), CLEC9A+ DCs, natural killer (NK) cells, and plasma cells were significantly associated with improved survival outcomes in NPC. Taken together, our findings represent a unique resource providing in-depth insights into the cellular heterogeneity of NPC TME and highlight potential biomarkers for anticancer treatment and risk stratification, laying a new foundation for precision therapies in NPC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41422-020-0374-x

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 463

Metadata

Authors
Chen, Y.-P., Yin, J.-H., Li, W.-F., Li, H.-J., Chen, D.-P., Zhang, C.-J., Lv, J.-W., Wang, Y.-Q., Li, X.-M., Li, J.-Y., Zhang, P.-P., Li, Y.-Q., He, Q.-M., Yang, X.-J., Lei, Y., Tang, L.-L., Zhou, G.-Q., Mao, Y.-P., Wei, C., Xiong, K.-X., Zhang, H.-B., Zhu, S.-D., Hou, Y., Sun, Y., Dean, M., Amit, I., Wu, K., Kuang, D.-M., Li, G.-B., Liu, N., & Ma, J.
Venue
Cell Research
Published
2020-07-20
Volume
30
Issue
11
Pages
1024-1042
ISSN
  • 1001-0602 (ISSN-L)
  • 1748-7838
OpenAlex
W3043438918
Cited by
463
References
20
FWCI
15.56
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. https://app.cochat.ai/papers/10.1038/s41422-020-0374-x
The paper
Chen, Y.-P., Yin, J.-H., Li, W.-F., Li, H.-J., Chen, D.-P., Zhang, C.-J., Lv, J.-W., Wang, Y.-Q., Li, X.-M., Li, J.-Y., Zhang, P.-P., Li, Y.-Q., He, Q.-M., Yang, X.-J., Lei, Y., Tang, L.-L., Zhou, G.-Q., Mao, Y.-P., Wei, C., . . . Ma, J. (2020). Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Research. https://doi.org/10.1038/s41422-020-0374-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.